Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBOS Group Limited ( (AU:EBO) ) has shared an update.
EBOS Group Limited has announced a change in the trustee of the EBOS Staff Share Plan, with Elizabeth Mary Coutts and Alistair Alexander Gray now serving as trustees. This change does not affect the number of shares held, indicating a strategic adjustment in the management of the company’s share plan without altering its current shareholding structure.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services including wholesale and distribution of healthcare, medical, and pharmaceutical products. The company focuses on serving the Australasian market with a strong emphasis on delivering value to its stakeholders through its comprehensive supply chain solutions.
Average Trading Volume: 86,262
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$7.19B
See more insights into EBO stock on TipRanks’ Stock Analysis page.